Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.250
-0.050 (-2.17%)
At close: Mar 31, 2025, 4:00 PM
2.217
-0.033 (-1.47%)
After-hours: Mar 31, 2025, 4:22 PM EDT

Mereo BioPharma Group Market Cap

Mereo BioPharma Group has a market cap or net worth of $357.75 million as of March 31, 2025. Its market cap has decreased by -19.89% in one year.

Market Cap
357.75M
Enterprise Value
294.38M
1-Year Change
-19.89%
Ranking
Category
Stock Price
$2.25

Market Cap Chart

Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $357.75M, an increase of 186.58%. That is a compound annual growth rate of 19.42%.

History

DateMarket Cap% Change
Mar 28, 2025365.70M-32.55%
Dec 31, 2024542.14M67.64%
Dec 29, 2023323.39M269.38%
Dec 30, 202287.55M-49.64%
Dec 31, 2021173.85M-28.05%
Dec 31, 2020241.63M276.02%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings